Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2012
12/13/2012WO2012149268A8 Tolerogenic synthetic nanocarriers for allergy therapy
12/13/2012WO2012142286A8 Methods for suppressing allergic reactions
12/13/2012WO2012135671A3 Monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
12/13/2012WO2012135637A3 Inhibition of macrophage-synthesized wnt7b to inhibit tumor angiogenesis and metastasis
12/13/2012WO2012126118A8 Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy
12/13/2012WO2012121529A3 Composition for nerve-cell or endothelial-cell regeneration comprising a ninjurin action suppressing agent
12/13/2012WO2012101509A3 Immunological compositions comprising hiv gp41 polypeptide derivatives
12/13/2012WO2005046613A3 Methods and compositions for the treatment of b cell lymphomas and other cancers
12/13/2012US20120315634 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues
12/13/2012US20120315323 Influenza hemagglutinin antibodies, compositions and related methods
12/13/2012US20120315321 Immunological methods and compositions for the treatment of alzheimer's disease
12/13/2012US20120315320 Uses of formulations of thyroid hormone analogs and nanoparticulate forms thereof to increase chemosensivity and radiosensitivity in tumor or cancer cells
12/13/2012US20120315297 Treatment of Psychological Trauma
12/13/2012US20120315295 Development of a Marker Foot and Mouth Disease Virus Vaccine Candidate That is Attenuated in the Natural Host
12/13/2012US20120315294 Needle-free administration of PRRSV vaccines
12/13/2012US20120315293 Antigen Delivery Vectors and Constructs
12/13/2012US20120315292 Immunogenic compositions for streptococcus pyogenes
12/13/2012US20120315291 Purine derivatives and their pharmaceutical uses
12/13/2012US20120315290 Inhibitors of ll-37 mediated immune reactivity to self nucleic acids
12/13/2012US20120315288 LOW DENSITY LIPOPROTEIN RECEPTOR-MEDIATED siRNA DELIVERY
12/13/2012US20120315287 Mic-binding antibodies and methods of use thereof
12/13/2012US20120315286 Compositions and methods related to tim 3, a th1-specific cell surface molecule
12/13/2012US20120315285 Antibody Formulation
12/13/2012US20120315284 Composition for enhancing trail sensitivity comprising inhibitors for expression or activity of tip41 as a target gene of trail sensitizer
12/13/2012US20120315283 Methods of promoting tissue growth and tissue regeneration
12/13/2012US20120315282 Antibodies Specific for TGF-Beta
12/13/2012US20120315281 Treatment of renal injury
12/13/2012US20120315280 Antibody therapy for use in the digestive tract
12/13/2012US20120315279 Compositions and method of modulating growth factor function
12/13/2012US20120315278 Human binding molecules having killing activity against enterococci and uses thereof
12/13/2012US20120315277 Compositions and Methods for the Therapy and Diagnosis of Influenza
12/13/2012US20120315276 Neutralizing prolactin receptor antibodies and their therapeutic use
12/13/2012US20120315275 Humanized anti-c5ar antibodies
12/13/2012US20120315274 Methods of Treating Glucose Metabolism Disorders
12/13/2012US20120315273 Treating skin cancer
12/13/2012US20120315272 Methods for prevention and treatment of inflammation using anti-chemokine antibodies
12/13/2012US20120315271 Methods for treating bone cancer by administering a nerve growth factor antagonist antibody
12/13/2012US20120315270 Rsv immunogens, antibodies and compositions thereof
12/13/2012US20120315269 Immunoglobulin-like transcript (ilt) receptors as cd8 antagonists
12/13/2012US20120315268 Combination therapy of an afucosylated cd20 antibody with bendamustine
12/13/2012US20120315267 Novel uses
12/13/2012US20120315266 Detecting complement activation
12/13/2012US20120315265 Hydrogel-forming polymer, and preparation process and uses thereof
12/13/2012US20120315264 Zwitterionic immunomodulators for the teatment of asthma and allergy
12/13/2012US20120315247 Compounds comprising a spiro-ring and methods of use
12/13/2012US20120315246 Compositions and methods for modulating inflammatory and/or immune responses
12/13/2012US20120315216 Compositions and Methods for Treating and Diagnosing Cancer
12/13/2012CA2838497A1 Therapeutic antibodies
12/13/2012CA2838217A1 Peptide carrier fusion proteins as allergy vaccines
12/13/2012CA2838211A1 Anti-pseudomonas psl binding molecules and uses thereof
12/13/2012CA2838188A1 Compositions and methods related to p6 of haemophilus influenzae
12/13/2012CA2837979A1 Macromolecules
12/13/2012CA2837767A1 Cetp fragments
12/13/2012CA2837357A1 Anti-ricin antibodies and uses thereof
12/13/2012CA2836805A1 Bovine vaccines and methods
12/13/2012CA2830415A1 Compositions and methods for inducing immune responses against bacteria in the genus staphylococcus
12/12/2012EP2532743A1 Pharmaceutical composition for treatment and/or prevention of cancer
12/12/2012EP2532681A1 Anti-ILT7 antibody
12/12/2012EP2532680A1 Medicinal composition for treating and/or preventing cancer
12/12/2012EP2532679A1 Human antibodies against il13 and therapeutic uses
12/12/2012EP2532678A1 Human antibodies against il13 and therapeutic uses
12/12/2012EP2532677A1 Human antibodies against il13 and therapeutic uses
12/12/2012EP2532367A1 Pharmaceutical agent for treatment and/or prevention of cancer
12/12/2012EP2532366A1 Pharmaceutical composition for treating and/or preventing cancer
12/12/2012EP2532365A1 Pharmaceutical composition for treatment and/or prevention of cancer
12/12/2012EP2532364A1 Pharmaceutical composition for treating and/or preventing cancer
12/12/2012EP2532363A1 Use of flagellins from the genus marinobacter as vaccination adjuvants
12/12/2012EP2532362A1 Vaccines including antigen from four strains of influenza virus
12/12/2012EP2532361A1 Pharmaceutical composition and methods to vaccinate against disseminated candidiasis and other infectious agents
12/12/2012EP2532360A1 Pharmaceutical compositions and methods to vaccinate against vaginal candidiasis
12/12/2012EP2532359A1 CETP fragments
12/12/2012EP2532358A1 Therapeutic Agent for Infections
12/12/2012EP2531859A2 Compositions and methods of modulating receptor protein tyrosine phosphatases
12/12/2012EP2531853A2 Use of novel markers of pluripotent stem cells
12/12/2012EP2531592A1 Fed-batch process using concentrated cell culture medium for the efficient production of biologics in eb66 cells
12/12/2012EP2531527A1 A monoclonal antibody to cd44 for use in the treatment of head and neck squamous cell carcinoma
12/12/2012EP2531261A2 Methods for diagnosis and treatment of non-insulin dependent diabetes mellitus
12/12/2012EP2531220A2 Active scaffolds for on-demand drug and cell delivery
12/12/2012EP2531218A1 Immunoglobulin preparation
12/12/2012EP2531217A1 Antibodies that bind to lysyl oxidase-like 2 (loxl2) and methods of use therefor
12/12/2012EP2531216A1 Icos critically regulates the expansion and function of inflammatory human th17 cells
12/12/2012EP2531215A1 Use of a specific mineral oil for the production of a novel adjuvant
12/12/2012EP2531214A1 Adjuvant for the preparation of vaccine compositions intended for the prevention of coccidiosis
12/12/2012EP2531213A2 Molecular complex for targeting antigens towards cells comprising antigens and uses thereof for vaccination
12/12/2012EP2531212A1 Bunyavirus vaccine
12/12/2012EP2531211A1 Method for sensitizing cells to cancer therapy
12/12/2012EP2531210A1 Vaccine and methods of use against strongyloides stercoralis infection
12/12/2012EP2531207A2 Methods and compositions for cancer immunotherapy using flagellin-tumor associated antigen fusion protein expressing tumor cells
12/12/2012EP2531185A2 Combination therapy for treating cancer comprising an igf-1r inhibitor and an hdac inhibitor
12/12/2012CN1964990B Antibodies specific for glycoprotein VI and methods of producing these antibodies
12/12/2012CN1890567B Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancer
12/12/2012CN1484650B Urocortin proteins and uses thereof
12/12/2012CN102822335A Pharmaceutical composition for treatment and/or prevention of cancer
12/12/2012CN102822201A Anti-HER3 antibodies and uses thereof
12/12/2012CN102822200A Combination of anti-CTLA4 antibody with diverse therapeutic regimens for the synergistic treatment of proliferative diseases
12/12/2012CN102822199A Medicinal composition for treating and/or preventing cancer
12/12/2012CN102821815A Treatment of chronic inflammatory conditions
12/12/2012CN102821790A Vaccines and immunotherapeutics comprising IL-15 receptor alpha and/or nucleic acid molecules encoding the same, and methods for using the same
12/12/2012CN102821789A Pharmaceutical composition for treatment and/or prevention of cancer
12/12/2012CN102821788A Pharmaceutical composition for treatment and/or prevention of cancer
1 ... 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 ... 1823